Conditions

Women who had gestational diabetes when pregnant may be at greater risk of developing pancreatic cancer, according to U.S. and Israeli researchers who said the study was the first to link the two diseases.

Some of the world’s largest pharma firms have set out what therapeutic areas and specific mechanisms are becoming more important to them, and which will be left by the wayside and we have the inside scoop. Click here to read Big Pharma’s Wish List

New and important evidence shows that Insulin Resistance Syndrome can lead to elevated risk for cardiovascular disease, breathing and sleep disorders, liver disease, Polycystic Ovarian Syndrome, type 2 diabetes, certain cancers, Alzheimer’s Disease and more.

Novartis expected to be in the market this year with Galvus, But the FDA is requiring more studies to determine Galvus’s safety, so they will not resubmit until probably mid-2009

A molecular compound found in red wine called resveratrol extends the life span of mice by up to 24 percent and up to 59 percent in other animals like flies and fish.

Markers of impaired glucose metabolism in nondiabetics were independently related to increased risks of all-cause and cardiovascular death in a large population-based study.

For diabetes and prediabetes screening, random plasma glucose testing alone appears to be at least as good as the full gamut of metabolic syndrome tests, and is easier and cheaper to boot, researchers found.

Insufficient numbers of women who had gestational diabetes during pregnancy are being screened for diabetes in the first year postpartum, according to a retrospective study.

High glycosylated hemoglobin levels in women with gestational diabetes are associated with the development of diabetes in the future, new research indicates.

Study found that when the women’s weight was taken into account, sleep apnea was associated with a doubling of the incidence of gestational diabetes and a fourfold increase in the risk of pregnancy-induced hypertension.